The Lamb Law Office Newsletter is a monthly communication from our law firm to help keep you up to date with some of the cases that we are working on for clients at the present time. In addition, we provide at least one information resource item per month, which you or someone you know might find helpful from time to time.
Past Newsletter Editions
For your convenience, below we have presented a summary and link for the most recent editions of the Lamb Law Office Newsletter.
September 2022 – In this newsletter, we provide information about Camp Lejeune claims for veterans and their family members who have been diagnosed with various types of cancers. Specifically, we address two “problems” people may be concerned about as regards Camp Lejeune claims involving cancers — that, in fact, are not problems at all, as explained in the featured article. We also include an FDA article about the recently approved COVID-19 bivalent vaccine boosters.
August 2022 – In this newsletter, we report on how to get legal compensation from the United States Government for Camp Lejeune cancer claims. Recent new federal legislation allows former Marines and their family members who lived on Camp Lejeune from 1953 to 1987 for 30 days or more, and who were later diagnosed with cancer, can now file a federal court lawsuit in the Eastern District of North Carolina. The legal basis for these lawsuits is the Camp Lejeune Justice Act of 2022. We also include an FDA article about how to stay safe in the sun.
July 2022 – In this newsletter, we cover the recent findings surrounding the increased incidences of anaplastic large-cell lymphoma (ALCL) associated with breast implants. We also provide information from the National Hurricane Center regarding storm preparation.
June 2022 – In this newsletter, we provide readers with the June 2022 EPA Water Health Advisory for per- and polyfluoroalkyl substances (PFAS). We also cover the litigation surrounding possible GenX water contamination cases.
May 2022 – In this newsletter, we cover the litigation surrounding Benzene, a widely-used chemical known to cause acute myelogenous leukemia (AML) and myelodysplastic syndrome (MDS). We also provide information regarding medical record copying costs by state.
April 2022 – In this newsletter, we provide readers with a brief overview of our current Asbestos, Benzene, Drug Injury and Breast Implant Lawsuits. We also provide an information resource reporting on every step to simple online security.
March 2022 – In this newsletter, we cover the drug injury litigation regarding the bladder cancer drug, Padcev, and the recent skin reactions involving toxic epidermal necrolysis (TEN) and Stevens-Johnson syndrome (SJS). We also provide information for ConsumerMedSafety.org, a free online health information resource.
February 2022 – In this newsletter, we cover the drug injury litigation regarding the three types of Mesothelioma in detail, providing background information for the topic. We also provide information for Medline Plus, a free online health information resource.
January 2022 – In this newsletter, we cover the recent side effect warning for Xeljanz, Rinvoq and Olumiant released by the FDA. We also provide readers with an updated information resource addressing COVID-19 self test FAQs and updated isolation and quarantine information.
December 2021 – In this newsletter, we cover the drug injury litigation regarding the recent updates in the Philips CPAP Machines Recall. We also provide readers with an updated information resource addressing COVID-19 vaccine booster shots FAQs.
November 2021 – In this newsletter, we cover bladder cancer drug, Padcev, and the recent skin reactions involving toxic epidermal necrolysis (TEN) and Stevens-Johnson syndrome (SJS). We also provide readers with an information resource addressing COVID-19 vaccine booster shots FAQs.
October 2021 – In this newsletter, we cover the recent side effect warning for Xeljanz released by the FDA. We also provide readers with an information resource addressing flu vaccine information.
September 2021 – In this newsletter, we provide research resources for drug safety and warnings information. We also provide readers with an information resource regarding FAQs surrounding children and the COVID-19 pandemic.
August 2021 – There was no newsletter sent out for the month of August in 2021.
July 2021 – In this newsletter, we cover the drug injury litigation regarding the recent Philips CPAP Machines Recall. We also provide readers with a new resource with medication safety tips for older adults.
June 2021 – In this newsletter, we cover the drug injury litigation regarding Mesothelioma / Lung Cancer / Asbestosis in detail, providing background information for the topic. We also provide readers with a new resource for Alzheimer’s and related Dementias.
May 2021 – In this newsletter, we provide readers with an information resource regarding hurricane and natural disaster preparedness. We also give readers a brief overview of our firm’s practice areas.
April 2021 – In this newsletter, we provide reader’s with information on how to check your credit report each week for free until 2022. We also provide various legal and medical resources to assist in locating useful, well-presented information.
March 2021 – In this newsletter, we cover three litigations which we are currently handling, Injectafer, Belviq and Ocaliva. We also provide information regarding the American Cancer Society’s Cancer Resource Center.
February 2021 – In this newsletter, we cover three litigations we are currently handling including Xeljanz, Beovu, and Asbestos in Talcum Powder Products. We also provide readers with information regarding individuals’ rights under HIPPA to access their health information.
January 2021 – In this newsletter, we provide readers with a brief overview of our current Drug Injury Lawsuits. We also provide information clarifying the differences between drug interactions, side effects, and allergies. Lastly, there is information from the CDC about the COVID-19 Vaccine.
December 2020 – In this newsletter, we cover the drug injury litigation regarding the SGLT2 Inhibitors class of diabetes drugs (Inovanka, Farxiga, Jardiance, etc.). We also provide information on how to report adverse drug reactions to the FDA MedWatch Program. In addition, we point out the updated CDC Domestic Travel Guidelines.
November 2020 – In this newsletter, we cover two different litigations which we are currently handling, Injectafer and GenX. We also provide information regarding CDC Holiday Gathering Recommendations.
October 2020 – In this newsletter, we cover these three litigation areas: Asbestos – Mesothelioma; Benzene; and, Belviq. We also provide information for Medline Plus, a free online health information resource.
September 2020 – In this newsletter, we cover a few litigations we are currently handling, Breast Implant Devices, Elmiron, and Beovu. We also provide information regarding medical record copying costs by state.
(Last Updated: October 5, 2022)
Newsletter Sign-up Form
You can sign up to receive our monthly newsletter by completing this form.